Neobe Therapeutics Ltd
13146056
Healthy
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 20/01/2026
Due 03/02/2027
Industry
Officers
director · Since 20/01/2021
BIOLOGIST
PORTUGUESE · UNITED KINGDOM · Age 41
director · Since 15/03/2023
CHAIRMAN OF THE BOARD
BRITISH · ENGLAND · Age 66
Also on 1 other board
director · Since 21/12/2023
INVESTMENT DIRECTOR
BRITISH · ENGLAND · Age 38
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr. Pedro Vaz De Almada Correa De Sampaio
Ceased 21/01/2024
Dr. Annelise Juliette Soulier
Ceased 21/01/2024
Charges1 outstanding
SPRK CAPITAL LIMITED
CompanyRankvs 340+ SIC 72110 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£694k
Balance sheet strength
Cash
£440k
Cash in the bank
Net Current Assets
£685k
Working capital
Current Assets
£822k
Current Liabilities
£137k
Fixed Assets
£9k
Debtors
£382k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 6.00 | -£437k |
| 2024 | 23.26 | +£1.1M |
| 2023 | 1.19 | — |
Derived from filed accounts. Not audited figures.